$4B UK Life Sciences Fund Reveals First U.S. Investments
... on tertiary biotech markets. Legal & General Capital, via its Ancora L&G partnership with U.S.-based developer Ancora, will develop in ... and VERO Biotech all have space in the building. Ancora L&G was also selected as the preferred developer of the Rhode ...